Genpact (G) Set to Announce Earnings on Thursday

Genpact (NYSE:GGet Free Report) is set to post its quarterly earnings results after the market closes on Thursday, November 7th. Analysts expect Genpact to post earnings of $0.71 per share for the quarter. Genpact has set its FY 2024 guidance at 3.140-3.180 EPS and its Q3 2024 guidance at EPS.Individual interested in registering for the company’s earnings conference call can do so using this link.

Genpact (NYSE:GGet Free Report) last issued its earnings results on Thursday, August 8th. The business services provider reported $0.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.64 by $0.05. The business had revenue of $1.18 billion for the quarter, compared to analyst estimates of $1.15 billion. Genpact had a net margin of 14.12% and a return on equity of 22.28%. On average, analysts expect Genpact to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Genpact Stock Performance

Shares of Genpact stock opened at $38.41 on Thursday. The firm has a market cap of $6.91 billion, a PE ratio of 10.91, a price-to-earnings-growth ratio of 1.60 and a beta of 1.13. The firm’s 50-day simple moving average is $38.88 and its 200-day simple moving average is $35.06. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.89 and a current ratio of 1.89. Genpact has a 1 year low of $29.41 and a 1 year high of $39.95.

Genpact Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 23rd. Investors of record on Monday, December 9th will be paid a dividend of $0.1525 per share. The ex-dividend date is Monday, December 9th. This represents a $0.61 annualized dividend and a yield of 1.59%. Genpact’s dividend payout ratio (DPR) is 17.43%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on G shares. JPMorgan Chase & Co. increased their price objective on shares of Genpact from $35.00 to $43.00 and gave the stock a “neutral” rating in a research note on Friday, September 6th. Needham & Company LLC raised their price target on shares of Genpact from $40.00 to $42.00 and gave the company a “buy” rating in a research note on Friday, August 9th. Robert W. Baird raised their price target on shares of Genpact from $38.00 to $44.00 and gave the company a “neutral” rating in a research note on Wednesday, October 9th. TD Cowen raised their price target on shares of Genpact from $35.00 to $36.00 and gave the company a “hold” rating in a research note on Friday, August 9th. Finally, Jefferies Financial Group raised their price target on shares of Genpact from $35.00 to $40.00 and gave the company a “hold” rating in a research note on Monday, September 9th. Eight research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, Genpact currently has a consensus rating of “Hold” and a consensus target price of $39.44.

Read Our Latest Analysis on Genpact

About Genpact

(Get Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Read More

Earnings History for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.